Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2026-06-08 @ 4:57 PM
Study NCT ID:
NCT00605566
Status:
COMPLETED
Last Update Posted:
2019-02-19
First Post:
2008-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors
Sponsor:
University Health Network, Toronto
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SOR-NET-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None